Tiger Global started to build up the position in Myriad Genetics in Q4 2013 and continued to invest until Q1 2014. Since then they sold 2.35 Million shares. The investor completely sold their stake between Q2 2014 and Q2 2015.
Myriad Genetics, Inc. has recently announced an exciting collaboration with Memorial Sloan Kettering Cancer Center (MSK) to delve into the realm of minimal r...
Best Stocks, 6 months agoSALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced...
GlobeNewswire, 10 months agoKwhen Finance, 12 months ago
Gene editing stocks present themselves as one of the more lucrative investments in the healthcare sector. Gene editing, a revolutionary take on the science o...
InvestorPlace, about 1 year ago